Skip to content

explorative study for the efficacy of low level laser therapy for the prevention of radiodermatitis

Explorative study for the efficacy of 633nm and 830nm wavelength Low level laser therapy for the PRevention of RAdiodermatitis :comparative study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0004950
Enrollment
32
Registered
2020-04-21
Start date
2018-12-04
Completion date
Unknown
Last updated
2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : This study is conducted for patients who are planning to undergo radiotherapy after breast cancer surgery. Surgery is divided into two groups, total mastectomy and breast conservative

Sponsors

Samsung Medical Center
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: a)10 patients who have undergone breast conservative surgery and 10 patients who have undergone total mastectomy b) Adult aged from 19 to 65 c) ECOG performance status 0-1 d)A person who voluntarily signs a written agreement in informed consent document and who can be followed up during the study period.

Exclusion criteria

Exclusion criteria: a) Patients who are of become pregnant b) Patients who have photosensitivity history c) Patients who are unable to comply with the provisions of the clinical trial. d) Inappropriate patients for this tiral judged by clinicians or investigators

Design outcomes

Primary

MeasureTime frame
severity of radiodermatitis, the difference of moisture, sebum, TEWL, erythema and pigment index between irradiated breast and the opposite breast

Secondary

MeasureTime frame
adverse event, inconvenience

Countries

Korea, Republic of

Contacts

Public ContactJI HYE PARK

Samsung Medical Center

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026